Consistently, in our current research, the presence of NOX4 was also discovered in COPD model mice and cells, and its level can be downregulated by luteolin, indicating that the effects of luteolin on inhibiting oxidative stress and inflammatory responses in COPD might be achieved by downregulating NOX4 level. This evidence concerns the gene NOX4 and chronic obstructive pulmonary disease.